Triazolone and triazolethione derivatives as inhibitors of...

Details Triazolone and triazolethione derivatives as inhibitors of... Triazolone and triazolethione derivatives as inhibitors of...

2006-07-11

2006-07-11

Lambkin, Deborah C. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S272400

Reexamination Certificate

active

07074810

ABSTRACT:
The present application describes novel hydantoin derivatives of formula (I):or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, L, and R11are defined in the present specification, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-α converting enzyme (TACE), aggrecanase, or a combination thereof.

REFERENCES:
patent: 5220018 (1993-06-01), Bock et al.
patent: 5438063 (1995-08-01), Osswald et al.
patent: 5641796 (1997-06-01), Dominianni et al.
patent: 5721263 (1998-02-01), Inada et al.
patent: 5750549 (1998-05-01), Caldwell et al.
patent: 6177587 (2001-01-01), Hashimoto et al.
patent: 6605722 (2003-08-01), Makovec et al.
patent: 0 520 423 (2003-05-01), None
patent: WO 97/14671 (1997-04-01), None
patent: WO 01/87866 (2001-11-01), None
patent: WO 02/30930 (2002-04-01), None

Affiliated with

Also associated with

Rating

Triazolone and triazolethione derivatives as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolone and triazolethione derivatives as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolone and triazolethione derivatives as inhibitors of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569913